secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2026-09-22T20:30:15+00:00
Accession:  0001193125-26-397996
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos raises $1.12M in registered direct offering of stock and pre-funded warrants
--------------------------------------------------------------------------------

- Sold 380,469 common shares at $1.46/share and 386,654 pre-funded warrants at $1.459 each for ~$1.12M gross.
- Net proceeds approximately $915,400.50 after fees; intended for general corporate and working capital purposes.
- Priced at-the-market under Nasdaq rules; Dawson James Securities acted as sole placement agent with 8% cash fee.
- Offering closed September 21, 2026; pre-funded warrants exercisable at $0.001, no expiration, 4.99% beneficial ownership limit.
- Officers and directors entered 15-day lock-up agreements restricting share transfers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000119312526397996/0001193125-26-397996-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000119312526397996/tcrt-20260918.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-397996

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer